[PR Newswire] - RALEIGH, N.C., Feb. 27, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced that the Company will host "Treatment of Pain and Opioid Dependence with Buprenorphine" ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment